• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组过表达筛选鉴定出能够绕过黑色素瘤中 p16 介导的衰老的基因。

Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.

机构信息

1 The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia.

Mater Research Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

出版信息

SLAS Discov. 2017 Mar;22(3):298-308. doi: 10.1177/1087057116679592. Epub 2016 Nov 23.

DOI:10.1177/1087057116679592
PMID:27872202
Abstract

Malignant melanomas often arise from nevi, which result from initial oncogene-induced hyperproliferation of melanocytes that are maintained in a CDKN2A/p16-mediated senescent state. Thus, genes that can bypass this senescence barrier are likely to contribute to melanoma development. We have performed a gain-of-function screen of 17,030 lentivirally expressed human open reading frames (ORFs) in a melanoma cell line containing an inducible p16 construct to identify such genes. Genes known to bypass p16-induced senescence arrest, including the human papilloma virus 18 E7 gene ( HPV18E7), and genes such as the p16-binding CDK6 with expected functions, as well as panel of novel genes, were identified, including high-mobility group box (HMGB) proteins. A number of these were further validated in two other models of p16-induced senescence. Tissue immunohistochemistry demonstrated higher levels of CDK6 in primary melanomas compared with normal skin and nevi. Reduction of CDK6 levels drove melanoma cells expressing functional p16 into senescence, demonstrating its contribution to bypass senescence.

摘要

恶性黑色素瘤通常起源于痣,痣是由黑素细胞最初的致癌基因诱导过度增殖引起的,这些黑素细胞处于 CDKN2A/p16 介导的衰老状态。因此,能够绕过这种衰老障碍的基因可能有助于黑色素瘤的发展。我们在含有诱导型 p16 构建体的黑色素瘤细胞系中进行了 17030 个人类开放阅读框 (ORF) 的功能获得筛选,以鉴定此类基因。鉴定出了已知能够绕过 p16 诱导的衰老阻滞的基因,包括人乳头瘤病毒 18 E7 基因 (HPV18E7),以及具有预期功能的 p16 结合 CDK6 等基因,以及一系列新基因,包括高迁移率族蛋白 (HMGB) 蛋白。其中一些在另外两种 p16 诱导的衰老模型中得到了进一步验证。组织免疫组织化学显示,与正常皮肤和痣相比,原发性黑色素瘤中 CDK6 的水平更高。降低 CDK6 水平可使表达功能性 p16 的黑色素瘤细胞进入衰老状态,表明其对绕过衰老的贡献。

相似文献

1
Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.全基因组过表达筛选鉴定出能够绕过黑色素瘤中 p16 介导的衰老的基因。
SLAS Discov. 2017 Mar;22(3):298-308. doi: 10.1177/1087057116679592. Epub 2016 Nov 23.
2
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.转基因BRAFV600E小鼠中的黑素细胞痣样增生和黑色素瘤
Oncogene. 2009 Jun 11;28(23):2289-98. doi: 10.1038/onc.2009.95. Epub 2009 Apr 27.
3
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.家族性黑色素瘤患者黑素细胞性病变中突变型p16蛋白的表达与定位
Hum Pathol. 2004 Jan;35(1):25-33. doi: 10.1016/j.humpath.2003.08.017.
4
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?痣中的细胞衰老与黑色素瘤中的永生化:p16的作用?
Br J Cancer. 2006 Aug 21;95(4):496-505. doi: 10.1038/sj.bjc.6603283. Epub 2006 Aug 1.
5
p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.人黑素细胞衰老、凋亡和永生化过程中p16/细胞周期蛋白依赖性激酶抑制剂2A缺乏:对黑色素瘤进展的潜在影响。
J Natl Cancer Inst. 2003 May 21;95(10):723-32. doi: 10.1093/jnci/95.10.723.
6
Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.cAMP 信号通路的激活以及黑色素生成的诱导与 p16(INK4) 和 p27(KIP1) 与细胞周期蛋白依赖性激酶(CDKs)的结合、E2F 结合活性的丧失以及人类黑素细胞的过早衰老相关。
Exp Cell Res. 1999 Dec 15;253(2):561-72. doi: 10.1006/excr.1999.4688.
7
Senescence-Like Phenotypes in Human Nevi.人类痣中的衰老样表型
Methods Mol Biol. 2017;1534:175-184. doi: 10.1007/978-1-4939-6670-7_17.
8
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.C-MYC过表达是持续抑制黑色素瘤细胞中癌基因诱导的衰老所必需的。
Oncogene. 2008 Nov 6;27(52):6623-34. doi: 10.1038/onc.2008.258. Epub 2008 Aug 4.
9
p15 Expression Differentiates Nevus from Melanoma.p15表达可区分痣与黑色素瘤。
Am J Pathol. 2016 Dec;186(12):3094-3099. doi: 10.1016/j.ajpath.2016.08.009. Epub 2016 Nov 14.
10
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.CDKN2B缺失促进从良性黑素细胞痣到黑色素瘤的进展。
Cancer Discov. 2015 Oct;5(10):1072-85. doi: 10.1158/2159-8290.CD-15-0196. Epub 2015 Jul 16.

引用本文的文献

1
CDKN2A and matrix metalloproteinases: key regulators of cellular senescence in squamous cell carcinoma.CDKN2A与基质金属蛋白酶:鳞状细胞癌中细胞衰老的关键调节因子
Am J Transl Res. 2025 Jun 15;17(6):4573-4589. doi: 10.62347/FKDS7259. eCollection 2025.
2
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition.极光 B 抑制剂促进 RB 低磷酸化和衰老,而不依赖于 p53 依赖性 CDK2/4 抑制。
Cell Death Dis. 2024 Nov 9;15(11):810. doi: 10.1038/s41419-024-07204-5.
3
A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.
一种多组学综合方法揭示了与NRAS 突变黑色素瘤靶向治疗后衰老逃逸相关的新基因和途径。
Cancer Gene Ther. 2023 Oct;30(10):1330-1345. doi: 10.1038/s41417-023-00640-z. Epub 2023 Jul 7.
4
A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy.一种三标志物特征可识别接受新辅助化疗的人类乳腺癌中的衰老情况。
Cancer Chemother Pharmacol. 2023 Apr;91(4):345-360. doi: 10.1007/s00280-023-04523-w. Epub 2023 Mar 24.
5
Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report.胚系和痣相关基因突变对一位快速进展性皮肤黑色素瘤患者的早期贡献:病例报告。
BMC Med Genomics. 2023 Jan 5;16(1):1. doi: 10.1186/s12920-022-01426-2.
6
Detection of Gene Mutations in Liquid Biopsy of Melanoma Patients: Overview and Future Perspectives.黑色素瘤患者液体活检中的基因突变检测:概述与未来展望。
Curr Treat Options Oncol. 2020 Feb 11;21(3):19. doi: 10.1007/s11864-020-0708-4.
7
An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.EBNA3C 缺失型 Epstein-Barr 病毒 (EBV) 突变体能在脐血人源化小鼠模型中导致潜伏期较长的 B 细胞淋巴瘤。
PLoS Pathog. 2018 Aug 20;14(8):e1007221. doi: 10.1371/journal.ppat.1007221. eCollection 2018 Aug.